Authors:
Kollmannsberger, C
Mayer, F
Kuczyk, M
Kanz, L
Bokemeyer, C
Citation: C. Kollmannsberger et al., Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy, WORLD J URO, 19(2), 2001, pp. 120-125
Authors:
Machtens, S
Serth, J
Bokemeyer, C
Bathke, W
Minssen, A
Kollmannsberger, C
Hartmann, J
Knuchel, R
Kondo, M
Jonas, U
Kuczyk, M
Citation: S. Machtens et al., Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features, INT J CANC, 95(5), 2001, pp. 337-342
Authors:
Kollmannsberger, C
Gerl, A
Schleucher, N
Beyer, J
Kuczyk, M
Rick, O
Gasper, J
Sosada, M
Rie, C
Kanz, L
Bokemeyer, C
Citation: C. Kollmannsberger et al., Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer, ANTI-CANC D, 11(7), 2000, pp. 535-539
Authors:
Souchon, R
Krege, S
Schmoll, HJ
Albers, P
Beyer, J
Bokemeyer, C
Classen, J
Dieckmann, KP
Hartmann, M
Heidenreich, A
Holtl, W
Kliesch, S
Kohrmann, KU
Kuczyk, M
Schmidberger, H
Weinknecht, S
Winter, E
Wittekind, C
Bamberg, M
Citation: R. Souchon et al., Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors. Results of an update conference based on evidence-based medicine (EBM), STRAH ONKOL, 176(9), 2000, pp. 388-405
Citation: M. Kuczyk et S. Machtens, Predictive value of decreased p27 Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients, PROSTATE C, 2, 1999, pp. S17-S17
Authors:
Serth, J
Kuczyk, M
Machtens, S
Bokemeyer, C
Herrmann, R
Hartmann, J
Knuchel, R
Jonas, U
Citation: J. Serth et al., Analysis of the cyclin-dependent kinase inhibitor p27(Kip1) in muscle invasive bladder cancer, ONCOL REP, 6(1), 1999, pp. 229-233
Authors:
Kuczyk, M
Serth, J
Bokemeyer, C
Machtens, S
Schwede, J
Herrmann, R
Paeslack, U
Truss, MC
Knuchel, R
Jonas, U
Citation: M. Kuczyk et al., The need for microdissectional tumor cell preparation during the moleculargenetic analysis of prostate cancer, WORLD J URO, 17(2), 1999, pp. 115-122
Citation: S. Machtens et al., New aspects on genetic alterations and biological prognostic parameters incancer of the prostate, ONKOLOGIE, 22(4), 1999, pp. 322-325
Authors:
Machtens, S
Kuczyk, M
Becker, AJ
Bokemeyer, C
Serth, J
Jonas, U
Citation: S. Machtens et al., New aspects on the identification of genetic alterations and prognostically important biological parameters in renal cell cancer, UROLOGE, 38(5), 1999, pp. 442-451
Authors:
Kuczyk, M
Munch, T
Machtens, S
Wunning, T
Grunewald, V
Stief, CG
Hofner, K
Jonas, U
Citation: M. Kuczyk et al., Therapy for kidney cell carcinoma with cava thrombus. Importancy of extracorporeal circulation and prognostic value of cranial tumor extension, UROLOGE, 38(5), 1999, pp. 460-465
Authors:
Albers, P
Siener, R
Hartmann, M
Weinknecht, S
Schulze, H
Rebmann, U
Kuczyk, M
deRiese, W
Loy, V
Bierhoff, E
Wittekind, C
Citation: P. Albers et al., Risk factors for relapse in stage I non-seminomatous germ-cell tumors: Preliminary results of the German Multicenter Trial, INT J CANC, 83(6), 1999, pp. 828-830
Citation: M. Kuczyk et al., Management of the post-chemotherapy residual mass in patients with advanced stage non-seminomatous germ cell tumors (NSGCT), INT J CANC, 83(6), 1999, pp. 852-855
Authors:
Kuczyk, M
Machtens, S
Hradil, K
Schubach, J
Christian, W
Knuchel, R
Hartmann, J
Bokemeyer, C
Jonas, U
Serth, J
Citation: M. Kuczyk et al., Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients, BR J CANC, 81(6), 1999, pp. 1052-1058
Authors:
Machtens, S
Kuczyk, M
Serth, J
Bokemeyer, C
Macheel, I
Jetscho, I
Hradil, K
Hermann, R
Hartmann, J
Thon, WF
Jonas, U
Citation: S. Machtens et al., Prognostic significance of cell cycle-associated genes p27(Kipf) and p21(WAF/Cip) for muscle-invasive carcinoma, AKT UROL, 29(7), 1998, pp. 341-348